Covagen is a biopharmaceutical company that develops bispecific fynomabs, utilizing human fynomer binding proteins fused to antibodies to create therapeutics with novel modes of action and enhanced efficacy in treating inflammatory diseases and cancer
Covagen is a biopharmaceutical company that develops bispecific fynomabs, utilizing human fynomer binding proteins fused to antibodies to create therapeutics with novel modes of action and enhanced efficacy in treating inflammatory diseases and cancer.